AUSTIN, Texas, Jan. 5, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual JP Morgan Healthcare Conference to be held January 9 -13, 2011, in San Francisco, CA.
The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) on Wednesday, January 12, 2011. The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.
About Luminex Corporation Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP technology can be obtained at www.luminexcorp.com. Contacts:
Harriss T. CurrieVice President, Finance and Chief Financial Officer512-219-8020Matthew ScaloSr. Director of Investor Relations512firstname.lastname@example.org
|SOURCE Luminex Corporation|
Copyright©2010 PR Newswire.
All rights reserved